TECX
Tectonic Therapeutic, Inc.
$35.48
-1.06 (-2.90%)
At close · Jul 8
Market Cap
$669.48M
Shares
18,869,186
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$35.48
Open$36.31
Day$34.66–37.75
52W$14.39–39.53
Avg vol 30d186K
Short int2.2M · 11.4% float · 16.7d
Short vol47%
Last earningsFeb 26, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+47%
above
Price vs 50-day avg
+19%
above
RSI (14)
61
neutral
MACD trend
Positive
52-week position
84%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+22%
trailing
6-month return
+80%
trailing
YTD return
+70%
this year
Relative strength
+72%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $30 › 200d $24 — 50d above 200d
Institutional flow
Distributing
3 of 112 funds reported for Jun 30 · net -45 sh shares · +1 new
Insider flow
Distributing
Net -$32.0K over 90 days · 100% sells
Short interest
Falling
11.41% of float · ▼ -8.1% MoM · 16.7 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
112 holders — near 2-yr high, broad support
Squeeze score
90
high risk · 0–100
Fundamentals
EPS growth
+41%
Y/Y
Free cash flow
$-60.3M
Balance sheet
$238.8M
net cash
Quant / Vol
risk profile
Volatility
82%
annualized · 1-yr
Max drawdown
−45%
past year
ATR
7.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+47%
Bullish
Price vs 50-day avg
+19%
Bullish
RSI (14)
61
Neutral
MACD trend
Positive
Bullish
52-week position
84%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $30 › 200d $24 — 50d above 200d
Institutional flow
Distributing
3 of 112 funds reported for Jun 30 · net -45 sh shares · +1 new
Insider flow
Distributing
Net -$32.0K over 90 days · 100% sells
Short interest
Falling
11.41% of float · ▼ -8.1% MoM · 16.7 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
112 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $14
Now $35 · 84%
52-wk high $40
vs 200-day avg +47%
vs 50-day avg +19%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TECX
this stock
Tectonic Therapeutic, Inc.
|
$669.48M | +70.1% | — | — | 11.4% |
|
ONC
BeOne Medicines Ltd.
|
$436.30B | -0.6% | +22179.2% | 887.9 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TECX | +3.2% | +21.9% | +79.7% | +3.2% | +70.1% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +3.4% | +21.1% | +72.2% | +3.4% | +60.8% |